Hepatoblastoma is a type of liver cancer usually seen in paediatric patients. Cancer develops when normally functioning cells undergo mutation and multiply out of control, forming a tumour mass. Cancer can happen in any tissue.
Both malignant and benign forms of tumours exist. If left untreated, a malignant tumour may quickly develop and metastasise (spread) to other organs. When a tumour is considered benign, it might still grow but will not metastasise.
Hepatoblastoma cancer is a very rare but malignant embryonal tumour that occurs in about 1% of all paediatric cancers, commonly seen in children under five years of age (toddler).
Hepatoblastoma meaning
While blastoma is a type of cancer common in children, seen in precursor cells, often called blasts, the prefix "hepato" talks about everything related to the liver; thus, hepatoblastoma demonstrates the origin of cancer in the liver of a child / toddler.
Being a rare tumour, hepatoblastoma comprises approximately 1% of all the prevailing paediatric cancers. Nevertheless, it must be understood that the rate of its incidence is slowly increasing in various parts of the world, especially the North America and Europe. Hepatoblastoma is found to be having a slight male predominance.
The liver is one of the crucial and largest parts of the body. It is located towards the upper right-hand portion of the abdominal cavity.
Nearly 1 pint of blood (13% of total volume) is stored in the liver at any time. There are many functions of the liver; few of them include:
Hepatoblastomas are broadly of two types, despite originating from primitive hepatic stem cells. The two types of hepatoblastomas are -
While the E-HB includes foetal, embryonal, pleomorphic, macro-trabecular, cholangioblastic, small cell undifferentiated (SCU) and mixed epithelial variants, the MEM-HB is subdivided into tumours with teratoid features (tissues not ordinarily present at the site) and tumours without teratoid features.
The seeds of hepatoblastoma cancer development are sown in utero, during the gestational period, primarily due to the inactivating mutations of the adenomatous polyposis coli (APC) gene. Also, very low birth weight (i.e., <1,500 g) is strongly associated with hepatoblastoma cancer. Reports supporting this association come from diverse nations, including the United States, the United Kingdom, the four Nordic countries (Denmark, Norway, Sweden and Finland), Japan, and China.
Hepatoblastoma cancer is closely related to genetic syndromes such as
The various other genes which could cause hepatoblastoma are:
The risk factors of hepatoblastoma are similar to most other types of cancers, including avoidable and non-avoidable risk factors. The various types of liver cancer risk factors include:
Pre-eclampsia, also called maternal hypertension, usually occurs during the gestational period and is one of the risk factors for many congenital disorders. Indulgence of tobacco and pre-eclampsia are known to reduce the birth weight of the newborn in the womb.
Assisted reproductive technology uses various procedures in infertile couples. The risk of prenatal hepatoblastoma is increased by nine times if the couple opts for any assisted reproductive technology, such as:
Being sporadic and mostly appearing in neonates and children, who cannot express their disease state as coherently or as articulately as adults, the presentation of hepatoblastoma symptoms in toddlers could be pretty tricky.
It is the parents' and caretakers' duty to contemplate and understand the abnormalities expressed in the child. The possible hepatoblastoma symptoms (if the tumour is intact) could include the following:
If the tumour is ruptured, the following symptoms can be seen along with the above:
In rare cases, precocious puberty (the changes of a child's body into that of an adult too soon) can also be seen due to the secretion of β-human chorionic gonadotropin (hCG) by the tumour.
Diagnosis of Hepatoblastoma is performed by hepatologist (liver specialist) by doing the following:
To treat Hepatoblastoma in children or adult, a team of hepatologists, liver transplant surgeons and oncologists may decide the treatment approach based on the condition of the patient, such as:
Untreated hepatoblastoma cancers usually results in death but both the disease and the treatment could also lead to few complications such as
The cure for hepatoblastoma depends on many factors, such as the sheer number and size of the tumours, the stage in which diagnosis was completed, etc. It must be understood that cancer cure rates are higher in children than in adult cancers.
The average age for the presentation of hepatoblastoma symptoms is from infancy to about five years of age. The symptoms usually appear within the first 18 months of life.
For children who are at risk for hepatoblastoma, the parents must take care to screen for hepatoblastoma before the onset of symptoms. Every three months until the kid is four years of age, an ultrasound of the abdomen and a blood test for alpha-fetoprotein must be performed.
While the traditional hepatoblastoma serum marker, alpha-fetoprotein (AFP), has limitations, novel serum indicators are being investigated. Glypican 3 (GPC3) is a highly effective histology immunomarker for hepatoblastoma.
Ultrasound (ultrasonography) produces sound waves which bounce off the organs producing echoes through which the organ is studied. Hyperechoic means "lots of echoes" which occur due to thin parenchyma. On ultrasonography, hepatoblastomas appear as mostly solid masses hyperechoic compared to the neighbouring liver.
Hepatoblastoma is an extremely uncommon kind of liver cancer that primarily affects children from infancy to 5 years of age. Five years after diagnosis, around 75-80% of children with hepatoblastoma are still alive. Chemotherapy and surgery, including liver transplantation, are used to treat hepatoblastoma.
Although the exact cause of hepatoblastoma is unknown, children who were born prematurely, have a low birth weight, or have a genetic condition (including, but not limited to, hemihypertrophy syndromes, Beckwith-Wiedemann, trisomy 18, and germline APC gene mutations) have an increased risk of developing hepatoblastoma.
The hepatoblastoma life expectancy (alive) is about five years in 75-80% of kids after diagnosis.
About 75-80% of kids with hepatoblastoma are still alive five years after being diagnosed. That survival rate goes up to 90% for kids whose tumours were found and treated early, usually through a mix of surgery and other treatments.
The hepatoblastoma chemotherapy protocol generally involves preoperative chemotherapy and postoperative chemotherapy.
It's an add-on test for diagnosing hepatoblastoma in children that aid hepatologists in knowing the extent of the liver metastasis. Depending on the time (before and after), they are categorised into two groups;
Both the groups have values 1 to 4 (I, II, III &IV). The higher the value, the deeper cancer has spread.
After surgery and chemotherapy treatment, the majority of the kids achieve complete or partial remission, but around 20% of them have a relapse within a year. After a hepatoblastoma recurrence, the mortality rate for the underlying condition rises dramatically.
Fill in the appointment form or call us instantly to book a confirmed appointment with our super specialist at 04048486868
Thank you for contacting us. We will get back to you as soon as possible. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
Whatsapp: 8977889778
Regards,
Pace Hospitals
Hitech City and Madinaguda
Hyderabad, Telangana, India.
Oops, there was an error sending your message. Please try again later. We will get back to you as soon as possible. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
Whatsapp: 8977889778
Regards,
Pace Hospitals
Hitech City and Madinaguda
Hyderabad, Telangana, India.
Metro Pillar Number C1772, Beside Avasa Hotel, Hitech City Road, Near HITEC City Metro Station, Hyderabad, Telangana, India.
Mythri Nagar, Beside South India Shopping Mall, Hafeezpet, Madeenaguda, Hyderabad, Telangana, India.
040 4848 6868
Payment in advance for treatment at PACE Hospitals, Hyderabad, Telangana, India (Pay in INR ₹)
For Bank Transfer:-
Scan QR Code by Any Payment App (GPay, Paytm, Phonepe, BHIM, Bank Apps, Amazon, Airtel, Truecaller, Idea, Whatsapp etc).
Thank you for subscribing to PACE Hospitals' Newsletter. Stay updated with the latest health information.
Oops, there was an error. Please try again submitting your details.
Disclaimer
General information on healthcare issues is made available by PACE Hospitals through this website (www.pacehospital.com), as well as its other websites and branded social media pages. The text, videos, illustrations, photographs, quoted information, and other materials found on these websites (here by collectively referred to as "Content") are offered for informational purposes only and is neither exhaustive nor complete. Prior to forming a decision in regard to your health, consult your doctor or any another healthcare professional. PACE Hospitals does not have an obligation to update or modify the "Content" or to explain or resolve any inconsistencies therein.
The "Content" from the website of PACE Hospitals or from its branded social media pages might include any adult explicit "Content" which is deemed exclusively medical or health-related and not otherwise. Publishing material or making references to specific sources, such as to any particular therapies, goods, drugs, practises, doctors, nurses, other healthcare professionals, diagnoses or procedures is done purely for informational purposes and does not reflect any endorsement by PACE Hospitals as such.